Avita Medical Ltd

Healthcare · Medical Devices

12.70$ +5.4% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

Avita Medical Ltd (RCEL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 48 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet RCEL
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	12	16	7.7	10	16	21	23	31	36	47	36	37	37	117	95	82	75	69	128	126	121	116	106	103	100	98	93	86	81	112	97	88	81	80	70	58	64	56	52	48
Current Assets	12	16	7.3	9.5	16	21	22	30	35	45	34	49	30	111	144	78	71	65	124	121	97	92	91	92	92	87	83	77	74	104	86	73	64	57	48	36	41	35	32	28
Cash	8.4	12	3.8	4.9	12	15	15	20	30	39	28	41	29	105	144	74	66	60	115	111	60	56	24	35	24	18	28	37	51	22	17	17	19	14	15	12	15	10	8.3	9.1
Cash & Short-Term Investments	8.4	12	3.8	4.9	12	15	15	20	30	39	28	41	30	105	144	74	66	60	115	111	90	85	83	84	84	79	73	66	60	89	68	54	44	36	26	16	23	18	14	11
Receivables	1.9	2.6	0.2	0.2	2.5	3.2	0.2	0.3	2.5	3.3	2.0	2.9	2.0	3.6	2.5	2.5	2.7	2.6	5.9	7.9	3.8	3.4	4.3	4.4	4.5	5.0	5.2	6.9	7.8	7.9	9.4	10	13	12	12	12	9.0	9.1	9.9	9.9
Inventory	1.1	1.5	1.0	1.4	1.1	1.4	1.2	1.6	1.1	1.5	1.0	1.5	1.1	1.6	1.1	1.1	1.7	2.3	1.8	1.6	1.9	2.1	1.8	2.0	2.0	2.1	2.8	3.1	4.4	5.6	7.2	6.7	6.2	7.3	8.4	7.5	7.2	6.9	6.1	5.3
Property, Plant & Equipment	–	–	–	–	0.0	–	–	–	0.9	0.9	1.8	1.8	5.3	5.3	3.7	3.7	3.6	3.3	3.3	2.9	3.1	2.8	2.5	2.5	2.3	2.1	–	3.2	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	–	–	–	–	0.0	–	–	–	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Intangible Assets	–	–	–	–	0.0	–	–	–	0.1	0.1	0.3	0.5	0.3	0.5	–	0.4	0.4	0.4	0.5	0.5	0.5	0.4	0.4	0.4	0.4	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.6	5.6	5.4	5.3	5.2	5.6	5.4	5.2
Total Liabilities	1.0	1.4	2.5	3.3	2.0	2.6	4.0	5.5	5.1	6.6	7.0	7.1	-31	14	-143	10	9.9	9.7	9.1	9.8	9.7	11	8.7	10	12	14	15	18	18	63	65	64	69	75	74	71	70	73	75	76
Current Liabilities	1.0	2.6	2.5	3.3	2.0	3.9	3.9	3.9	5.0	4.6	6.3	4.5	6.4	11	7.7	7.7	7.7	7.9	7.1	7.4	7.1	9.1	6.5	7.9	9.5	11	11	14	12	13	12	14	17	20	23	63	62	63	67	69
Short-Term Debt	–	–	–	–	0.0	–	–	–	0.0	0.0	0.0	0.0	0.0	0.5	–	–	–	0.0	1.1	0.9	–	0.7	–	–	0.7	0.6	0.6	0.7	0.9	0.9	0.9	0.8	–	0.9	–	42	42	44	46	47
Accounts Payable	0.9	1.0	1.0	1.0	1.7	0.3	0.3	0.3	4.5	1.9	2.7	2.7	2.7	6.2	4.3	4.3	3.6	2.8	3.6	3.1	2.4	2.7	2.4	2.5	3.6	3.0	3.8	3.8	3.0	3.8	4.5	4.2	4.2	6.3	8.7	7.3	8.1	9.0	7.2	6.4
Long-Term Debt	–	–	–	–	0.0	–	–	–	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	40	41	41	43	42	41	–	–	–	–	–
Shareholders' Equity	11	15	5.1	6.7	15	19	19	26	31	40	29	42	31	103	143	72	65	60	119	116	111	105	98	93	88	85	78	69	63	49	33	24	12	4.5	-4.6	-13	-6.7	-17	-23	-28
Retained Earnings	-125	-174	-132	-173	-139	-181	-149	-202	-164	-212	-215	-311	-218	-277	-195	-195	-205	-211	-217	-221	-227	-236	-245	-252	-257	-263	-272	-282	-291	-298	-317	-332	-348	-360	-374	-384	-397	-408	-419	-427
Shares Outstanding	5.8	5.8	7.6	7.6	8.0	8.0	11	11	9.8	9.8	22	22	19	20	21	21	22	22	23	25	25	24	25	25	25	25	25	25	25	25	26	26	26	26	26	26	28	30	29	31

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings